SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-04-014355
Filing Date
2004-09-30
Accepted
2004-09-30 17:09:56
Documents
5
Period of Report
2004-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f02132e8vk.htm 8-K 18684
2 EXHIBIT 2.2 f02132exv2w2.txt EX-2.2 203906
3 EXHIBIT 99.1 f02132exv99w1.txt EX-99.1 28220
4 EXHIBIT 99.2 f02132exv99w2.txt EX-99.2 55698
5 EXHIBIT 99.3 f02132exv99w3.txt EX-99.3 54633
  Complete submission text file 0000950134-04-014355.txt   363226
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 041055882
SIC: 2833 Medicinal Chemicals & Botanical Products